Cargando…
Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer
Targeting mitochondria via nano platform emerged as an attractive anti-tumor pathway due to the central regulation role in cellar apoptosis and drug resistance. Here, a mitochondria-targeting nanoparticle (TOS-PDA-PEG-TPP) was designed to precisely deliver polydopamine (PDA) as the photothermal agen...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362997/ https://www.ncbi.nlm.nih.gov/pubmed/35958515 http://dx.doi.org/10.1093/rb/rbac051 |
_version_ | 1784764832727171072 |
---|---|
author | Meng, Ziyu Wang, Binchao Liu, Yiqiang Wan, Yejian Liu, Qianshi Xu, Huasheng Liang, Renchuan Shi, Ying Tu, Peng Wu, Hong Xu, Chuan |
author_facet | Meng, Ziyu Wang, Binchao Liu, Yiqiang Wan, Yejian Liu, Qianshi Xu, Huasheng Liang, Renchuan Shi, Ying Tu, Peng Wu, Hong Xu, Chuan |
author_sort | Meng, Ziyu |
collection | PubMed |
description | Targeting mitochondria via nano platform emerged as an attractive anti-tumor pathway due to the central regulation role in cellar apoptosis and drug resistance. Here, a mitochondria-targeting nanoparticle (TOS-PDA-PEG-TPP) was designed to precisely deliver polydopamine (PDA) as the photothermal agent and alpha-tocopherol succinate (α-TOS) as the chemotherapeutic drug to the mitochondria of the tumor cells, which inhibits the tumor growth through chemo- and photothermal- synergistic therapies. TOS-PDA-PEG-TPP was constructed by coating PDA on the surface of TOS NPs self-assembled by α-TOS, followed by grafting PEG and triphenylphosphonium (TPP) on their surface to prolong the blood circulation time and target delivery of TOS and PDA to the mitochondria of tumor cells. In vitro studies showed that TOS-PDA-PEG-TPP could be efficiently internalized by tumor cells and accumulated at mitochondria, resulting in cellular apoptosis and synergistic inhibition of tumor cell proliferation. In vivo studies demonstrated that TOS-PDA-PEG-TPP could be efficiently localized at tumor sites and significantly restrain the tumor growth under NIR irradiation without apparent toxicity or deleterious effects. Conclusively, the combination strategy adopted for functional nanodrugs construction aimed at target-delivering therapeutic agents with different action mechanisms to the same intracellular organelles can be extended to other nanodrugs-dependent therapeutic systems. |
format | Online Article Text |
id | pubmed-9362997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93629972022-08-10 Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer Meng, Ziyu Wang, Binchao Liu, Yiqiang Wan, Yejian Liu, Qianshi Xu, Huasheng Liang, Renchuan Shi, Ying Tu, Peng Wu, Hong Xu, Chuan Regen Biomater Research Article Targeting mitochondria via nano platform emerged as an attractive anti-tumor pathway due to the central regulation role in cellar apoptosis and drug resistance. Here, a mitochondria-targeting nanoparticle (TOS-PDA-PEG-TPP) was designed to precisely deliver polydopamine (PDA) as the photothermal agent and alpha-tocopherol succinate (α-TOS) as the chemotherapeutic drug to the mitochondria of the tumor cells, which inhibits the tumor growth through chemo- and photothermal- synergistic therapies. TOS-PDA-PEG-TPP was constructed by coating PDA on the surface of TOS NPs self-assembled by α-TOS, followed by grafting PEG and triphenylphosphonium (TPP) on their surface to prolong the blood circulation time and target delivery of TOS and PDA to the mitochondria of tumor cells. In vitro studies showed that TOS-PDA-PEG-TPP could be efficiently internalized by tumor cells and accumulated at mitochondria, resulting in cellular apoptosis and synergistic inhibition of tumor cell proliferation. In vivo studies demonstrated that TOS-PDA-PEG-TPP could be efficiently localized at tumor sites and significantly restrain the tumor growth under NIR irradiation without apparent toxicity or deleterious effects. Conclusively, the combination strategy adopted for functional nanodrugs construction aimed at target-delivering therapeutic agents with different action mechanisms to the same intracellular organelles can be extended to other nanodrugs-dependent therapeutic systems. Oxford University Press 2022-08-01 /pmc/articles/PMC9362997/ /pubmed/35958515 http://dx.doi.org/10.1093/rb/rbac051 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Meng, Ziyu Wang, Binchao Liu, Yiqiang Wan, Yejian Liu, Qianshi Xu, Huasheng Liang, Renchuan Shi, Ying Tu, Peng Wu, Hong Xu, Chuan Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
title | Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
title_full | Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
title_fullStr | Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
title_full_unstemmed | Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
title_short | Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
title_sort | mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362997/ https://www.ncbi.nlm.nih.gov/pubmed/35958515 http://dx.doi.org/10.1093/rb/rbac051 |
work_keys_str_mv | AT mengziyu mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT wangbinchao mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT liuyiqiang mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT wanyejian mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT liuqianshi mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT xuhuasheng mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT liangrenchuan mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT shiying mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT tupeng mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT wuhong mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer AT xuchuan mitochondriatargetingpolydopaminecoatednanodrugsforeffectivephotothermalandchemosynergistictherapiesagainstlungcancer |